One minute of bromocriptine irreversibly inhibits prolactin release for hours

This publication has 13 references indexed in Scilit:

• Biphasic Luteinizing Hormone Secretion in Response to Gonadotropin-Releasing Hormone during Continuous Perifusion of Dispersed Rat Anterior Pituitary Cells: Changes in Total Release and the Phasic Components during the Estrous Cycle*
  Endocrinology, 1983
• Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone
  Molecular and Cellular Endocrinology, 1982
• SELECTIVE GROWTH HORMONE AND CYCLIC AMP STIMULATING ACTIVITY IS PRESENT IN A HUMAN PANCREATIC ISLET CELL TUMOR
  Journal of Clinical Endocrinology & Metabolism, 1982
• Decreased Responsiveness of GH₃Cells to the Dopaminergic Inhibition of Prolactin*
  Endocrinology, 1980
• A Broad Spectrum of Prolactin Suppression by Bromocriptine in Hyperprolactinemic Women: A Study of Serum Prolactin and Bromocriptine Levels after Acute and Chronic Administration ofBromocriptine*
  Journal of Clinical Endocrinology & Metabolism, 1980
• Evidence for an irreversible interaction of bromocryptine with central dopamine receptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1980
• Ergot alkaloids: Interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles
  European Journal of Pharmacology, 1980
• Differential effects of dopamine antagonists on prolactin secretion from cultured rat pituitary cells
  Life Sciences, 1978
• Direct Inhibition by Ergocornine of Pituitary Prolactin Release
  Endocrinology, 1971
• On some physiological actions of ergot
  The Journal of Physiology, 1906